Disease/Infection News

RSS

Three quarters of UK adults have received both doses of COVID-19 vaccine

Three quarters of adults in the UK have now received both doses of a COVID-19 vaccine, as the public continues to do what it can to protect themselves, their loved ones and their community.

10 Aug 2021

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

A pilot study has begun to assess the antibody response to a third dose of an authorized COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.

10 Aug 2021

Study reveals link between COVID-19 infection in pregnancy and preterm birth

Individuals who contract COVID-19 while pregnant face a higher risk of having a very preterm birth, as well as any preterm birth, according to a large study led by researchers at UC San Francisco.

10 Aug 2021

Systematic anatomical study specifies guidelines for performing nasopharyngeal swabs

Since the start of the coronavirus pandemic, thousands of nasopharyngeal swabs have been taken in Austria - millions worldwide.

10 Aug 2021

New estimate of total immunity to SARS-CoV-2 in Texas

According to researchers in Texas, a lack of appropriate testing in the US has led to an underestimation of seroprevalence in the U.S., thus making it difficult to estimate population immunity to SARS-CoV-2 or vaccination.

10 Aug 2021

Study explores ‘brain fog’ following COVID-19

A recent survey conducted in the United Kingdom revealed that approximately one in every five experiences prolonged coronavirus disease 2019 (COVID-19) symptoms five weeks post-infection. Also, one in seven people reported persistent symptoms even after twelve weeks.

10 Aug 2021

Cardioprotective role of HIF1α in COVID-19 patients

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first emerged in Wuhan, China, in late December 2019, has quickly become the most urgent issue facing scientists worldwide. It has been reported that the respiratory infection causes cardiac dysfunction in 25-55% patients, including hospitalized patients and non-critical patients.

10 Aug 2021

Antiviral activity of lipid-modified remdesivir in comparison to common remdesivir

In new research, scientists evaluated the broad-spectrum antiviral activity of ODBG-P-RVn, an orally available, lipid-modified monophosphate prodrug of the remdesivir parent nucleoside (GS-441524) against viruses that cause diseases of human public health concern, including SARS-CoV-2.

10 Aug 2021

SARS-CoV-2 Iota variant increases mortality risk among older adults

The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.

10 Aug 2021

SARS-CoV-2 variants and their ability to infect mice

A new study published on the bioRxiv* preprint server has conducted in silico studies along with in vitro, in vivo, and in situ observations and indicated the mouse adaptation of SARS-CoV-2.

10 Aug 2021

Evaluation of COVID-19 risk among international travelers in the UK for safety purposes

A high risk of transmission of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, is associated with international travel.

9 Aug 2021

New protocol for the study of SARS-CoV-2's medium and long-term outcomes

The clinical symptoms of the severe COVID-19 have been well described. In addition, scientists have defined the post-acute COVID-19 as the development of sequelae or persistence of symptoms several weeks after the onset of COVID-19 symptoms. In some cases, the symptoms persist for around 3-4 weeks, and in other cases of chronic COVID-19, symptoms may persist beyond 12 weeks from the onset of symptoms.

9 Aug 2021

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

A recent study in Colorado used real-world data to evaluate if individuals with chronic conditions have reduced antibody response to COVID-19 mRNA vaccines. The study investigated whether some medical conditions may impact antibody response to the mRNA vaccines.

9 Aug 2021

Controlling the spread of SARS-CoV-2 at a large public university

Researchers from the U.S. recently reported a multimodal "SHIELD: Target, Test, and Tell" program that helped mitigate the transmission of SARS-CoV-2 at a large public university. The program also prevented community transmission and helped the continuation of in-person classes during the pandemic. This study is available on the medRxiv* preprint server.

9 Aug 2021

Disease/Infection News

Three quarters of UK adults have received both doses of COVID-19 vaccine

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

Study reveals link between COVID-19 infection in pregnancy and preterm birth

Systematic anatomical study specifies guidelines for performing nasopharyngeal swabs

New estimate of total immunity to SARS-CoV-2 in Texas

Study explores ‘brain fog’ following COVID-19

Cardioprotective role of HIF1α in COVID-19 patients

Antiviral activity of lipid-modified remdesivir in comparison to common remdesivir

SARS-CoV-2 Iota variant increases mortality risk among older adults

SARS-CoV-2 variants and their ability to infect mice

Evaluation of COVID-19 risk among international travelers in the UK for safety purposes

New protocol for the study of SARS-CoV-2's medium and long-term outcomes

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

Controlling the spread of SARS-CoV-2 at a large public university

Study explores the role of structural inequality on COVID-19 incidence and outcomes

A multi-scale cryo-correlative platform to image SARS-CoV-2 in Vero cells

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

New study aims to determine the prevalence of COVID-related heart inflammation among elite athletes

Young, healthy adult infected by COVID-19 suffers CNS lymphocytic vasculitis

Research finds disruption of flight-or-fight response in healthy young people diagnosed with COVID-19

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News